Results 71 to 80 of about 2,173,693 (307)

Molecular Dynamics‐Guided Sterol Engineering of mRNA‐Lipid Nanoparticles Reprograms Biodistribution and Enhances Spleen‐Selective Immunity

open access: yesAdvanced Science, EarlyView.
Sterol engineering enables precise control of mRNA lipid nanoparticles by tuning membrane organization. Replacing cholesterol with bile acid‐derived sterols redirects protein expression from the liver to the spleen. Notably, CA‐20 LNP enhances antigen‐specific immune responses while exhibiting a favorable safety profile, highlighting sterols as a ...
Sanghyuk Jeon   +27 more
wiley   +1 more source

Immunization Information System Functional Standards, 2013-2018 [PDF]

open access: yes
The purpose of this document is to define and provide supporting references to the Immunization Information System (IIS) Functional Standards for 2013-2018.

core  

Strategic Consensus on a Proposed Vaccination Schedule for Adults in Portugal

open access: yesActa Médica Portuguesa
n/a.
Laura Moura   +10 more
doaj   +1 more source

Chronic HBV Infection Disrupts CCL5‐Secreting cNK Cells and Attenuates Liver Accumulation and Activation of DCs and HBV‐Specific T Cells

open access: yesAdvanced Science, EarlyView.
ADORA2A activation suppresses NFκB‐dependent CCL5 production in cNK cells during chronic HBV infection, disrupting intrahepatic DC recruitment and HBV‐specific CD8+ T‐cell differentiation and function. Targeting the ADORA2A/NFκB/CCL5 axis restores antiviral immunity and facilitates HBV clearance.
Ailu Yang   +9 more
wiley   +1 more source

Immunization Information System Functional Standards Version 4.1 Resource Guide [PDF]

open access: yes
This document lists primary resources associated with the IIS Functional Standards v 4.1. The resources were created collaboratively and vetted with the immunization information systems (IIS) community unless otherwise noted.

core  

Integrated Single‐Cell and TCR Profiling Reveals Protection‐Associated CD8+ T Cell Subsets Linked to Viral Control in PRRSV

open access: yesAdvanced Science, EarlyView.
PRRSV vaccine‐mediated protection is associated with clonally expanded cytotoxic CD8+ T cell subsets driven by viral structural proteins and supported by innate TLR4/TLR8 signaling and CD4+ T cell help, whereas non‐protective responses are characterized by dysfunctional exhausted‐like CD8+ T cells linked to poor viral control.
Can Kong   +14 more
wiley   +1 more source

Immunization Information System Functional Standards Version 4.2 Resource Guide [PDF]

open access: yes
This document lists primary resources associated with the IIS Functional Standards v 4.1. The resources were created collaboratively and vetted with the immunization information systems (IIS) community unless otherwise noted.

core  

An Aggregation‐Induced Polymerization Poly(Disulfide)‐Drug Nanoplatform for Autoimmune Uveitis Therapy via Inhibiting the cGAS‐STING Pathway

open access: yesAdvanced Science, EarlyView.
A cationic poly(disulfide)‐drug nanoplatform (LA/DexP) was developed to treat experimental autoimmune uveitis (EAU). With potent blood‐retinal barrier penetrability, LA/DexP releases DSP in response to high ROS and scavenges cfDNA to inhibit the cGAS‐STING signaling pathway.
Yuelan Wu   +12 more
wiley   +1 more source

Immunization Information System Functional Standards Version 4.0 Resource Guide [PDF]

open access: yes
This document lists primary resources associated with the IIS Functional Standards v 4.0 (Standards). The resources were created collaboratively and vetted with the immunization information systems (IIS) community unless otherwise noted.

core  

Trends in immunization completion and disparities in the context of health reforms: the case study of Tanzania. [PDF]

open access: yes, 2010
\ud Of global concern is the decline in under five children mortality which has reversed in some countries in sub Saharan Africa (SSA) since the early 1990 s which could be due to disparities in access to preventive services including immunization.
Semali Innocent A   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy